Wednesday, 2 October 2019

CAScination partners with Triputra Technomed in Indonesia

Distribution agreement Indonesia Triputra CAScination

Swiss medtech company CAScination has signed a distribution agreement with PT Triputra Technomed. The company is specialized in distributing radiology equipment. It will sharpen its distinctive profile by adding CAScination’s product portfolio for microinvasive liver cancer treatment. “We see a great potential for CAScination products to help hospitals in Indonesia doing high quality ablations under CT-guidance for better results and quicker recovery of the patients.”, says Triputra Technomed CEO Marc Sahuleka.

Ct-guidance for the treatment of liver cancer is not yet standard of care in Indonesia. But demand for efficient and accurate tumor treatment will grow, Triputra CEO Marc Sahuleka is convinced: “We can help hospitals by supporting them in doing biopsies and ablations with high accuracy and speed. Once doctors are trained and comfortable with the CAScination workflow, more difficult treatments will also be possible to the benefit of patients suffering from liver cancer.”

“We are glad to have a partner who is well established in the Indonesian health care sector and enthusiastic about launching new treatment methods for better patient outcomes. The key to Quality Ablation is our unique workflow: 2D and 3D planning, precise navigation of the needle, easy validation of the placement and accurate treatment of the lesion. The result of your treatment is controlled directly after the intervention to make sure all tumors have been destroyed. We are very happy that Quality Ablation is now also offered in Indonesia", says Frank Koall, Chief Commercial Officer at CAScination AG.

CAS-One tumor treatment was introduced to the Indonesian market during a roadshow in early September, visiting some of the countries’ most important centers for cancer treatment. Demand for liver cancer treatments is expected to be high in Indonesia. Amongst males it is the second most common form of cancer, only surpassed by lung cancer. “The big cancer centers in the country, that are striving to bring their services in cancer and pain management to the next level, are always interested in the latest treatments for their patients”, Marc Sahuleka, Triputa Technomed CEO.

Triputa Technomed was founded in 2010 and has since managed to establish itself as a premium partner for sales and distribution of radiology equipment and consumables such as x-ray films, computed radiography, ultrasound devices, ct and mri scanners. The company is based in Makassar, with subsidiaries in Jakarta, Surabaya, and Denpasar with its customer base spreading all over Indonesia from Aceh in the West to Papua in the East.

 

CAScination AG is an award-winning medical technology company dedicated to development, manufacturing and commercialization of innovations in computer-assisted and image-guided surgery. Our trailblazing navigation systems and surgical robots are designed to improve outcomes for patients undergoing surgical or interventional procedures and offer new perspectives to patients worldwide. Our CAS-One planning and navigation system is used to treat patients suffering from soft tissue cancer (e.g., liver cancer) by many hospitals across Europe, and we are developing further applications in a number of disease areas.

 

Contact
CAScination AG
Steigerhubelstrasse 3
CH-3008 Bern
Fon + 41 (0) 31 552 0440
info@cascination.com
www.cascination.com

 

 

Downloads